NEW YORK, Sept. 20, 2026 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of HDFC Bank Limited (NYSE: HDB) between July 17, 2023 to May 26, 2026, inclusive (the "Class Period"), of the important October 13, 2026 lead plaintiff deadline.

So What: If you purchased HDFC Bank securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the HDFC Bank class action, go to https://rosenlegal.com/cases/hdfc-bank-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 13, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) HDFC Bank camouflaged payments as marketing spend to pay higher interest to a state firm in order to induce deposits; (2) these activities were approved by senior management; (3) these activities likely violated regulations and HDFC Bank's own policies, including those that prohibit payments that could constitute improper inducement; (4) as a result of the foregoing, HDFC Bank's interest income and operating expenses were overstated; and (5) as a result of the foregoing, defendants' positive statements about HDFC Bank's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the HDFC class action, go to https://rosenlegal.com/cases/hdfc-bank-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     [email protected]

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

National class action law firm offers free, confidential case evaluations to AECOM employees, clients, and others whose personal information may have been exposed in the reported AECOM data breach.

DALLAS, Sept. 20, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at AECOM, the U.S.-based multinational infrastructure and engineering firm. Anyone who has received a data breach notice from AECOM, or who believes their personal information may have been exposed, can request a free case evaluation.

AECOM data breach — at a glance:

- Company: AECOM, a Texas-based, multibillion-dollar multinational infrastructure consulting, engineering, design, and construction management firm.

- Reported: A cyberattack said to have occurred on or about September 17, 2026, first surfaced on dark web monitoring sites.

- Hackers' claims: The group Metaencryptor claimed responsibility for an attack said to involve approximately 1.22 terabytes (TB) of data. Separately, dark web monitoring service Breachsense listed a related AECOM leak of roughly 670GB attributed to a group identified as BrainCipher.

- Status: The breach and the hackers' claims remain unconfirmed. AECOM has not publicly detailed the scope or impact.

- Who may be affected: Current and former AECOM employees, clients, and others whose data AECOM held.

- Cost to you: Nothing. Case evaluations are free and confidential.

What Happened

According to a September 17, 2026 post on the dark web monitoring site Ransomware.live, the hacker group Metaencryptor claimed responsibility for a cyberattack on AECOM that allegedly affected about 1.22 TB of data. The cybersecurity blog HookPhish similarly reported that Metaencryptor was behind a suspected attack on the engineering firm.

Separately, the dark web monitoring service Breachsense reported an AECOM data leak listed at approximately 670GB, attributed to a group it identified as BrainCipher. Breachsense also indexed thousands of AECOM-linked credentials circulating online, including 27,434 @aecom.com accounts drawn from external breaches and 6,077 credentials tied to aecom.com itself — among them thousands of logins found in "combo lists" and in infostealer malware logs, many with plaintext passwords. Breachsense cautioned that those credentials may belong to either customers or staff and are not necessarily connected to the claimed attack.

The breach has not been confirmed, and important details (including its true scope, the specific data involved, and the number of people affected) are not yet publicly available.

What Personal Information May Be at Risk

The specific data involved in the reported AECOM data breach has not been confirmed. Data breaches like this can expose personal information, increasing the risk of identity theft and fraud. Affected individuals should treat any AECOM breach notification seriously.

Who May Be Affected by the AECOM Data Breach

The investigation focuses on current and former AECOM employees, clients, and anyone else whose personal information AECOM maintained. Anyone who has received a data breach notification from AECOM may face an increased risk of identity theft and fraud and is encouraged to come forward.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action to pursue legal remedies on behalf of individuals whose sensitive personal data may have been compromised in the reported AECOM breach. A successful case could recover compensation for losses such as lost time, out-of-pocket costs, and loss of privacy, and could push AECOM to strengthen how it protects personal information. The firm will evaluate your rights and potential claims at no cost.

Recommended Steps to Protect Yourself

- Review your account statements and credit reports regularly and stay alert for suspicious activity.

- Confirm whether your information was involved in the AECOM incident.

- Preserve any letters or emails you received about the breach.

- Consider placing fraud alerts and enrolling in credit monitoring.

Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492; Email: [email protected]; Web: www.edelson-law.com. Or click HERE to request a free consultation.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud.

Media and Partnership Inquiries: Use the contact information above to connect with our team regarding interviews, co-counsel opportunities, and referral partnerships.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee a similar outcome. The reported data breach and the hackers' claims described above are unconfirmed.

SOURCE Edelson Lechtzin LLP

Share this article

During this past week, South Korea and Kazakhstan signed commercial agreements worth US$18.95 billion. Kazakhstan is a country of 20 million people with its core industries being oil and gas, and among the highest producers of iron and silver in the world. Uzbekistan is a country of 39 million people, and they are the largest electricity producer in Central Asia.

Qazaqstan Investment Corporation (QIC) is Kazakhstan's national fund of funds and are anchor investors along with IT Park Ventures, the venture capital arm of the country's state technology park. The new venture capital fund will back Central Asian startups at the Series A and later, which are businesses with a proven model that are ready to scale beyond the region. The fund is sector-agnostic but focuses on AI-native companies, where artificial intelligence is core to the product and business model.

"Higgsfield becoming Kazakhstan's first unicorn was a turning point. It showed that a world-class AI company can be built in Central Asia. And it won't be the last with more than half of the region's population is under 30, growing up digital and our governments actively investing in AI. Yet the region is still largely overlooked by international investors, and that's the opportunity this fund is built for," explained Aslan Sultanov, Co-founder and General Partner at SparkLabs Mirae Silk Road.

Former Coinbase CTO and Partner at Andreessen Horowitz, Balaji Srinivasan, reopened his Network School in Kazakhstan last month. Telegram launched an AI lab and opened their first regional office in Kazakhstan this past year.

Beyond capital, portfolio companies will gain access to the SparkLabs and Mirae Asset's global networks, along with hands-on support in expanding into South Korea, the United States and the MENA region.

About the Partners

SparkLabs Group is a network of startup accelerators and venture capital funds that has invested in over 600 startups across 6 continents since December 2013. These companies include OpenAI, SpaceX, Vectara, Kneron, Anthropic, Nex Team, Kraken, GenG, Lyft, MetAI, and others.

Mirae Asset Venture Investment is the venture capital arm of Mirae Asset Financial Group, one of Asia's largest independent financial groups with over US$845 billion in assets under management. The company operates worldwide across 18 markets, and manages a fully diversified global investment platform encompassing ETFs, alternative investments, and traditional strategies.

Qazaqstan Investment Corporation (QIC) is Kazakhstan's national fund of funds and part of Baiterek National Managing Holding. QIC invests in private equity and venture capital funds alongside international and private partners, with the goal of attracting long-term capital into Kazakhstan and developing the country's investment ecosystem. QIC participates in 19 funds with a combined capitalization of $2.8 billion.

IT Park Ventures is the venture capital arm of IT Park Uzbekistan, the country's state technology park and the main platform supporting Uzbekistan's IT industry and tech exports. IT Park Ventures invests in startups from Uzbekistan and Central Asia and co-invests with international funds, connecting regional founders with global capital and markets.

SOURCE SparkLabs Group

Share this article

SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: INCY), to commercialise, distribute, and register ruxolitinib cream (registered as Opzelura® in the U.S. and European Union) in Australia.

Ruxolitinib (1.5%) cream is a novel, topical Janus kinase (JAK) inhibitor.[1] In the U.S., OPZELURA is indicated for the topical treatment of non-segmental vitiligo in adults and pediatric patients 12 years of age and older, as well as for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.[2]

Under the terms of the expanded agreement, Incyte will remain responsible for the development and manufacturing of ruxolitinib cream, while ST will manage regulatory submissions, medical affairs, marketing, and distribution across Australia.

ST Chief Executive Officer, Mr Carlo Montagner, welcomed the addition of ruxolitinib cream to ST's portfolio, marking a key expansion into inflammatory dermatology.

"Our partnership with Incyte began in 2021, and we are pleased to extend this collaboration into dermatology," said Mr Montagner. "Atopic dermatitis and vitiligo are chronic skin conditions that carry a significant physical and psychosocial burden for patients.[3],[4] Bringing ruxolitinib cream to the Australian market aligns with our ongoing commitment to providing innovative therapies for conditions where substantial unmet medical needs remain."

"Our immediate priority will be navigating the local regulatory and reimbursement pathways to ensure eligible Australian patients gain equitable and timely access to this topical treatment," Mr Montagner added.

Incyte Head of International, Lee Heeson, noted that the expanded agreement reinforces the strong operational alignment between the two organisations.

"We are pleased to expand our partnership with Specialised Therapeutics as we work to make ruxolitinib cream available to eligible patients in Australia," said Lee Heeson, Executive Vice President and Head of Incyte International. "ST's proven experience navigating regulatory, medical and commercial pathways across the region makes them a valued partner as we continue to broaden access to our portfolio globally."

ST anticipates progressing regulatory and reimbursement submissions for OPZELURA with Australian healthcare authorities in due course.

– ENDS –

About Specialised Therapeutics

Founded in 2007, Specialised Therapeutics is an independent specialty pharmaceutical company, providing novel therapies and technologies to patients in Australia, New Zealand and across Southeast Asia. Headquartered in Singapore, ST partners with global pharmaceutical, biotech and diagnostic companies to bring novel healthcare opportunities to patients who are impacted by a range of diseases. ST has built a strong track record of success, navigating complex regulatory, reimbursement and commercialisation environments in its diverse regions across multiple therapeutic areas. The ST mission is to provide specialty therapies where there is an unmet need to communities that would otherwise not have ready access to such therapies. The company's broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, neurology, endocrinology, ophthalmology and dermatology, although it is not confined to these areas. Additional information can be found at www.stbiopharma.com.

About Ruxolitinib Cream (OPZELURA)

Ruxolitinib cream (OPZELURA) a novel cream formulation of Incyte's selective JAK1/JAK2 inhibitor ruxolitinib, approved by the U.S. FDA for the topical treatment of nonsegmental vitiligo in patients 12 years of age and older, is the first and only treatment for repigmentation approved for use in the United States. OPZELURA is also approved in the U.S. for the topical short-term and non-continuous chronic treatment of mild to moderate AD in non-immunocompromised patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. Use of OPZELURA in combination with therapeutic biologics, other JAK inhibitors, or potent immunosuppressants, such as azathioprine or cyclosporine, is not recommended.[2]

In Europe, OPZELURA (ruxolitinib) cream 15mg/g is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age and in adult patients with moderate atopic dermatitis (AD) for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate.[5]

Incyte has worldwide rights for the development and commercialisation of OPZELURA. To date, more than one million patients globally have been treated with OPZELURA.

OPZELURA is a registered trademark of Incyte.

References:

SOURCE Specialised Therapeutics

Share this article

NEW YORK, Sept. 20, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

So what: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23523 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

What is this about: On February 27, 2026, Reuters published an article entitled "Wall Street hit by UK mortgage lender collapse, raising fears of more credit 'cockroaches.'" The article stated that lenders were "rocked by the implosion of little-known UK mortgage provider Market Financial Solutions Ltd ["MFS"], fuelling concerns about wider losses among banks and reviving warnings of more "cockroaches" in the booming private credit industry." It further stated that another publication "reported Barclays has a 600 million pound ($809.70 million) exposure to MFS."

On this news, Barclays American Depositary Shares ("ADS") fell 3.99% on February 27, 2026, and 2.3% on March 2, 2026.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     [email protected]

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

NEW YORK, Sept. 20, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 13, 2026.

So what: If you purchased AST SpaceMobile securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the AST SpaceMobile class action, go to https://rosenlegal.com/cases/ast-spacemobile-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 13, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) AST SpaceMobile's increasing capital requirements were likely to increase AST SpaceMobile's debt load and share dilution with greater frequency and at greater scale than defendants had signaled to investors; (2) accordingly, defendants had overstated the sufficiency of AST SpaceMobile's capital and liquidity position to achieve AST SpaceMobile's strategic and business goals; (3) defendants likewise overstated the durability of AST SpaceMobile's competitive position in the satellite D2C market; (4) even following the EchoStar Transaction, defendants continued overstating AST SpaceMobile's competitive position in the satellite D2C market; (5) AST SpaceMobile was experiencing slow user adoption in the U.S. and Japan; (6) the foregoing was likely to have a significant negative impact on AST SpaceMobile's business and financial prospects; and (7) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the AST SpaceMobile class action, go to https://rosenlegal.com/cases/ast-spacemobile-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

NEW YORK, Sept. 20, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Baidu, Inc. (NASDAQ: BIDU) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Baidu securities between November 18, 2025 and August 17, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/baidu-inc-bidu-class_action_lawsuit.

Baidu Case Details

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:

(1) Baidu overstated the ability of its AI business to mitigate rapid declines in its legacy online marketing business;

(2) as a result, Baidu's revenue was reasonably likely to decline; and

(3) as a result of the foregoing, Defendants' positive statements about Baidu's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

What's Next for Baidu Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/cases/baidu-inc-bidu-class_action_lawsuit. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Baidu you have until November 13, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Baidu Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Baidu Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE Bronstein, Gewirtz & Grossman, LLC

Share this article

NEW YORK, Sept. 20, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AST SpaceMobile, Inc. (NASDAQ: ASTS) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AST SpaceMobile securities between March 4, 2025 and July 15, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/ast-spacemobile-inc-asts-class_action_lawsuit.

AST SpaceMobile Case Details

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:

- AST SpaceMobile's increasing capital requirements were likely to increase the Company's debt load and share dilution with greater frequency and at a greater scale than Defendants had represented to investors;

- as a result, Defendants overstated the sufficiency of AST SpaceMobile's capital and liquidity position to achieve its strategic and business goals;

- Defendants overstated the durability of AST SpaceMobile's competitive position in the satellite direct-to-cell ("D2C") market;

- even following the EchoStar Transaction, Defendants continued to overstate AST SpaceMobile's competitive position in the satellite D2C market;

- AST SpaceMobile was experiencing slow user adoption in the United States and Japan;

- the foregoing was likely to have a significant negative impact on AST SpaceMobile's business and financial prospects; and

- as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

What's Next for AST SpaceMobile Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/cases/ast-spacemobile-inc-asts-class_action_lawsuit. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in AST SpaceMobile you have until November 13, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to AST SpaceMobile Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for AST SpaceMobile Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE Bronstein, Gewirtz & Grossman, LLC

Share this article

NEW YORK, Sept. 20, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Doximity, Inc. (NYSE: DOCS) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Doximity securities between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/doximity-inc-docs-class_action_lawsuit.

Doximity Case Details

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:

- Doximity overstated the impact of its Newsfeed on the Company's revenue growth;

- Doximity was losing market share to competitors offering more favorable pricing and engagement models;

- despite Defendants' representations regarding Doximity's advertising practices, the Company relied heavily on banner advertisements and email newsletters as advertising methods; and

- as a result, Defendants' statements regarding Doximity's Newsfeed, revenue growth, market position, engagement, and advertising practices were materially false and/or misleading at all relevant times.

What's Next for Doximity Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/cases/doximity-inc-docs-class_action_lawsuit. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Doximity you have until November 16, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Doximity Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Doximity Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE Bronstein, Gewirtz & Grossman, LLC

Share this article

NEW YORK, Sept. 20, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AppLovin Corporation (NASDAQ: APP) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AppLovin securities between February 12, 2026 and August 5, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/applovin-corporation-app-class_action_lawsuit.

AppLovin Case Details

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:

- the generative AI video creative feature for AppLovin's Ads platform was subject to significant development delays, making its release on AppLovin's stated timeline unlikely;

- Defendants overstated the consistency with which AppLovin was improving its AI models;

- AppLovin significantly overstated the benefits and reliability of the purported "virtuous cycle" and "compounding" value proposition provided by its AI models to customers and the Company; and

- as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

What's Next for AppLovin Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/cases/applovin-corporation-app-class_action_lawsuit. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in AppLovin you have until November 16, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to AppLovin Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for AppLovin Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE Bronstein, Gewirtz & Grossman, LLC

Share this article